Delivery Order SPE2DR25D3301-SPE2DR26F18EZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Envarsus XR 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order valued at $5,412.39, with performance to be completed by December 5, 2025, at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,811.00 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on October 29, 2025, with completion targeted for November 20, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for a specialized immunosuppressant medication. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,288.86 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for 100 tablets of Envarsus XR 1 mg, a pharmaceutical product used in transplant immunosuppression therapy. This firm fixed price contract with an ultimate completion date of September 17, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (100-count supply) on November 14, 2025, with a firm fixed price ceiling value of $1,358.25 and an ultimate completion date of December 8, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order valued at $1,811.00 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Envarsus XR 1 mg tablets (100-count package). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies an ultimate completion date of December 5, 2025, and the pharmaceutical product will be delivered to AmerisourceBergen's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,577.72 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg, a pharmaceutical product for immunosuppression. The contract, awarded on July 31, 2025, with completion targeted for August 21, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,718.48 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,358.64 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 0.75 mg tablets (100 count) on November 18, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,718.48 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $1,288.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Envarsus XR 1 mg tablets in quantities of 100 units. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of August 4, 2025, with performance to be executed at the awardee's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18EZDelivery Order
The Defense Logistics Agency awarded a $1,811.00 delivery order to AmerisourceBergen Drug Corp for Envarsus XR 1 mg tablets (100-count package) on November 18, 2025, with completion scheduled for December 10, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of a specialized immunosuppressant medication for federal medical supply needs. The award was issued under no set-aside designation, reflecting the contractor's capability to compete openly in the federal pharmaceutical marketplace. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen Drug Corp serves critical federal healthcare procurement needs across the Defense Health Agency and military healthcare systems. The parent IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, with this specific delivery order fulfilling immediate supply requirements for Envarsus XR medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/18/25 |